Literature DB >> 3179181

The effect of fractionation of light treatment on necrosis and vascular function of normal skin following photodynamic therapy.

K Benstead1, J V Moore.   

Abstract

Sparing of normal tissue, mouse tail skin, by fractionation of light treatment in photodynamic therapy has been demonstrated in BDF1 mice injected with 2 mg tetrasodium-meso-tetra(4-sulphophenyl)porphine dodecahydrate i.v. When the time between 2 fractions of 67.5 J cm-2 and 90 J cm-2 was increased to 2 and 4 days respectively the incidence of necrosis fell to that expected after a single fraction. Blood flow in the tail skin 5 days after the second light fraction, as measured by the clearance of an intradermally injected solution of 133xenon in 0.9% saline, returned to control values when the time between 2 fractions was 2 days with 67.5 J cm-2 fractions, and 3 days with 90 J cm-2 fractions. The time course of recovery of normal mouse tail skin from photodynamic therapy, as shown by these split dose experiments, was found to be similar to the time course for the recovery of blood flow following a single light treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179181      PMCID: PMC2246602          DOI: 10.1038/bjc.1988.208

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Measurement of regional circulation by the local clearance of radioactive sodium.

Authors:  S S KETY
Journal:  Am Heart J       Date:  1949-09       Impact factor: 4.749

2.  Photodynamic inactivation of cancer cells in vitro. Effect of irradiation temperature and dose fractionation.

Authors:  J Moan; T Christensen
Journal:  Cancer Lett       Date:  1979-05       Impact factor: 8.679

3.  Computer programmes for fitting Puck and probit survival curves.

Authors:  C W Gilbert
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1969

4.  The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment.

Authors:  B G Ward; I J Forbes; P A Cowled; M M McEvoy; L W Cox
Journal:  Am J Obstet Gynecol       Date:  1982-02-01       Impact factor: 8.661

5.  Photoradiation therapy for cutaneous and subcutaneous malignancies.

Authors:  T J Dougherty
Journal:  J Invest Dermatol       Date:  1981-07       Impact factor: 8.551

6.  Photoinactivation of Chinese hamster cells by hematoporphyrin derivative and red light.

Authors:  C J Gomer; D M Smith
Journal:  Photochem Photobiol       Date:  1980-09       Impact factor: 3.421

7.  Photosensitization and split-dose recovery in cultured human urinary bladder carcinoma cells containing nonexchangeable hematoporphyrin derivative.

Authors:  D A Bellnier; C W Lin
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

8.  Treatment of vaginal carcinoma with laser photoirradiation following administration of haematoporphyrin derivative. Report of a case.

Authors:  H Soma; K Akiya; S Nutahara; H Kato; Y Hayata
Journal:  Ann Chir Gynaecol       Date:  1982

9.  The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin.

Authors:  J Moan; E O Pettersen; T Christensen
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

10.  Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture.

Authors:  T Christensen; A Wahl; L Smedshammer
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

View more
  3 in total

1.  Quantitative histological changes in murine tail skin following photodynamic therapy.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

2.  The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

3.  Vascular function and tissue injury in murine skin following hyperthermia and photodynamic therapy, alone and in combination.

Authors:  J V Moore; C M West; A K Haylett
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.